Clinical Trial Update: Value of Pharmacokinetic Assays in the Prediction of Induction and Maintenance Therapeutic Response in Crohn's Disease [Phase 4]

View source ↗

Summary

Phase 4 trial investigating the value of pharmacokinetic assays to predict induction and maintenance therapeutic response in Crohn's disease, terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease

Snippet

Sponsor: Centre Hospitalier Universitaire de Saint Etienne | Conditions: Crohn Disease | Phase 4 | Status: TERMINATED